Johnson & Johnson (BSP:JNJB34) Other Long-Term Liabilities : R$60,086 Mil (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Johnson & Johnson Other Long-Term Liabilities?

Johnson & Johnson's other long-term liabilities for the quarter that ended in Mar. 2025 was R$60,086 Mil.

Johnson & Johnson's quarterly other long-term liabilities increased from Sep. 2024 (R$82,641 Mil) to Dec. 2024 (R$107,066 Mil) but then declined from Dec. 2024 (R$107,066 Mil) to Mar. 2025 (R$60,086 Mil).

Johnson & Johnson's annual other long-term liabilities declined from Dec. 2022 (R$68,437 Mil) to Dec. 2023 (R$65,648 Mil) but then increased from Dec. 2023 (R$65,648 Mil) to Dec. 2024 (R$107,066 Mil).

Johnson & Johnson Other Long-Term Liabilities Historical Data

The historical data trend for Johnson & Johnson's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson Other Long-Term Liabilities Chart

Johnson & Johnson Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long-Term Liabilities

Get a 7-Day Free Trial

61,448.30

60,428.26

68,436.73

65,647.52

107,066.45

Johnson & Johnson Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25
Other Long-Term Liabilities	Get a 7-Day Free Trial															75,868.60	82,640.59	107,066.45	60,085.77	-

Johnson & Johnson Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Johnson & Johnson Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Johnson & Johnson Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (BSP:JNJB34) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

JNJ:USA JNJ:Peru JNJ:Mexico JNJ_KZ:Kazakhstan 1JNJ:Italy JNJd:UK 0R34:UK JNJ0:Germany JNJ:Germany JNJ:Germany JNJ:Germany JNJ:Germany JNJ:Canada JNJ:Bulgaria JNJ:Austria JNJ:Argentina

Address

One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933

Website

https://www.jnj.com

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.

Johnson & Johnson Headlines

No Headlines